Details for Patent: 7,553,818
✉ Email this page to a colleague
Summary for Patent: 7,553,818
| Title: | Combination therapy for effecting weight loss and treating obesity |
| Abstract: | The present invention features a novel therapy for effecting weight loss which involves treating a subject with a sympathomimetic agent (e.g., phentermine or a phentermine-like drug) in combination with an anticonvulsant sulfamate derivative (e.g., topiramate) such that the subject experiences weight loss. The combination methods of the present invention also are effective against symptoms associated with Syndrome X. The invention also features pharmaceutical compositions and kits for use in the practice of these novel therapies. |
| Inventor(s): | Najarian; Thomas (Los Osos, CA) |
| Assignee: | Vivus, Inc. (Mountain View, CA) |
| Application Number: | 11/385,198 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,553,818 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 7,553,818
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,553,818
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 369126 | ⤷ Sign Up | |||
| Australia | 2008262566 | ⤷ Sign Up | |||
| Australia | 5489600 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
